Preliminary Registration Report: Analytica 2012 on the Road to Success

A total of 633 exhibitors have already registered for the fair (compared to 586 in 2009). As a result, the International Trade Fair for Laboratory Technology and Analysis currently has eight percent more registered visitors than it did at this same point the last time that the fair was held.

“These positive interim results surpass the results from the last time this event was held,” explains Norbert Bargmann, Deputy CEO of Messe München GmbH. “This strong response demonstrates the trust that the industry places in analytica. We are collaborating with the industry to further develop our successful concept and reach new visitor target groups with new ideas.” As the industry association SPECTARIS announced at its autumn gathering in early September, the fact that interest is so high reflects the industry’s optimism for the coming year. “Most companies are looking optimistically into the future. Given the way that business is currently developing, they appear to be right. I assume that the industry will continue its growth trend of the past few years both in 2011 and again in 2012, provided that growth is not stifled by problems in the financial world again,” said Mathis Kuchejda, Chairman of the SPECTARIS association.

Thanks to the three-day analytica Conference, the international trade fair will once again bridge the gap between science and industry. The scientific conference is being organised by Forum Analytik, which consists of Germany’s three leading scientific associations, i.e. GDCh (German Chemical Society), GBM (German Society for Biochemistry and Molecular Biology) and DGKL (German Society for Clinical Chemistry and Laboratory Medicine). Renowned scientists from around the world will discuss the latest developments, current trends and future technologies. The topics being covered during the three-day conference range from new spectroscopy techniques for chemical analysis to challenges in separation and analysis techniques and analysing bioactive compounds.